ScreenerHero

SFZN Siegfried Holding AG

SWX · CH · Healthcare · Drug Manufacturers - Specialty & Generic · siegfried.ch
69.40CHF-0.57%Mkt Cap: 3.47B $P/E: 17.75

Siegfried Holding AG, together with its subsidiaries, engages in contract development and manufacturing of active pharmaceutical ingredient (API) and finished dosage forms worldwide. It offers drug substances, including …

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$64.30BUSDP/E 25.0
TAK
Takeda Pharmaceutical Company Limited
$56.90BUSD
TEVA
Teva Pharmaceutical Industries Limited
$46.26BUSDP/E 66.1
HLN
Haleon plc
$38.79BUSDP/E 18.0
ZTS
Zoetis Inc.
$29.51BUSDP/E 11.7
ZOE
Zoetis Inc.
$28.27BUSDP/E 12.1
UTHR
United Therapeutics Corporation
$23.01BUSDP/E 19.2
VTRS
Viatris Inc.
$20.24BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.14BUSDP/E 110.6
NBIX
Neurocrine Biosciences, Inc.
$14.66BUSDP/E 21.1
IPN
Ipsen S.A.
$12.60BUSDP/E 22.8
ELAN
Elanco Animal Health Incorporated
$11.25BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.26BUSDP/E 28.0
KRK
Krka, d. d.
$8.59BUSDP/E 19.2
ALKS
Alkermes plc
$7.17BUSDP/E 112.5
AMRX
Amneal Pharmaceuticals, Inc.
$7.09BUSDP/E 41.5
HIMS
Hims & Hers Health, Inc.
$6.92BUSD
LNTH
Lantheus Holdings, Inc.
$6.54BUSDP/E 24.3
KNSA
Kiniksa Pharmaceuticals International, plc
$5.87BUSDP/E 77.1
APTX
Apotex Health Corp.
$5.17BUSD

Key Statistics

Company
Market Cap3.47B USD
Enterprise Value4.43B USD
Revenue (TTM)1.53B USD
Gross Profit404.01M USD
Net Income (TTM)192.49M USD
Revenue/Share30.54 CHF
Last Price69.40 CHF
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees4.5K
CountryCH
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)17.75
P/E (Forward)14.79
PEG1.30
EV/EBITDA12.27
EV/Revenue2.90
P/S2.28
P/B3.08
EPS (TTM)3.91
EPS (Forward)4.72
52W Range
65.0512% of range101.60
52W High101.60 CHF
52W Low65.05 CHF
Profitability
Gross Margin26.66%
Oper. Margin14.09%
EBITDA Margin23.60%
Profit Margin12.70%
ROE14.95%
ROA7.83%
Growth
Revenue Growth2.20%
Earnings Growth4.00%
Cash Flow & Leverage
Operating CF260.40M USD
CapEx (TTM)264.18M USD
FCF Margin-10.27%
FCF Yield-4.53%
Net Debt935.92M USD
Net Debt/EBITDA2.59
Balance Sheet
Debt/Equity93.09
Current Ratio3.45
Quick Ratio1.36
Book Value/Sh22.65 CHF
Cash/Share2.39 CHF
Dividends
Fwd Div Rate0.40 CHF
Trail. Div Rate0.40 CHF
Div. Yield0.57%
5Y Avg Yield0.43%
Payout Ratio10.26%
Ex-Div DateApr 28, 2026
Pay DateApr 24, 2025
Splits
Last Split10:1
Split DateApr 28, 2025
Analyst Consensus
Rating2.0 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)100.58 CHF
Upside (mean)+44.9%
Target Range77.00 CHF – 140.00 CHF
77.00+44.9% to mean140.00
# Analysts12
Ownership
Shares Out.43.81M
Float39.90M
Insiders13.23%
Institutions55.15%
Technical
SMA 5074.45 (-6.8%)
SMA 20078.21 (-11.3%)
Beta0.81
S&P 52W Chg14.58%
Avg Vol (30d)121.11K
Avg Vol (10d)93.91K
Technical Indicators
RSI (14)37.1
MACD-0.8145
MACD Signal-0.5010
MACD Hist.-0.3136
BB Upper75.36 CHF
BB Middle72.30 CHF
BB Lower69.24 CHF
BB Width8.47%
ATR (14)1.979 CHF
Vol Ratio (20d)1.04x